Warning: fopen(/home/virtual/epih/journal/upload/ip_log/ip_log_2025-01.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 95 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 96 Changes in the prevalence of metabolic syndrome in Korean adults after the COVID-19 outbreak
Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health

OPEN ACCESS
SEARCH
Search
Advanced Search
mobile menu button

Articles

Page Path
HOME > Epidemiol Health > Volume 44; 2022 > Article
COVID-19
Original Article
 Changes in the prevalence of metabolic syndrome in Korean adults after the COVID-19 outbreak
Ji-Young Kwonorcid, Sang-Wook Songorcid
Epidemiol Health 2022;44:e2022101.
DOI: https://doi.org/10.4178/epih.e2022101
Published online: November 5, 2022

Department of Family Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea

Correspondence: Sang-Wook Song, Department of Family Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, 93 Jungbu-daero, Paldal-gu, Suwon 16247, Korea, E-mail: fmssw@catholic.ac.kr
• Received: August 10, 2022   • Accepted: November 5, 2022

© 2022, Korean Society of Epidemiology

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

prev next
  • 6,418 Views
  • 118 Download
  • 3 Web of Science
  • 4 Crossref
  • 4 Scopus
Full Article

Download PDF Download PDF

  • OBJECTIVES
    This study sought to reveal changes in the prevalence of metabolic syndrome (MetS) after the start of the coronavirus disease 2019 (COVID-19) pandemic and to identify the groups showing the greatest changes.
  • METHODS
    We compared the prevalence of MetS between 2017–2019 (i.e., the 3-year period before the COVID-19 pandemic) and soon after the initial outbreak of COVID-19 in 2020 among 24,564 adults ≥19 years of age using data from the Korea National Health and Nutrition Examination Survey.
  • RESULTS
    The prevalence of MetS increased steadily between 2017 and 2020 (29.4 to 35.3%, p for trend <0.001), with annual percent changes of 2.0%p, 2.2%p, and 1.7%p, respectively. Compared to 3 years before the COVID-19 pandemic, the prevalence of MetS significantly increased during the COVID-19 pandemic in males (6.2%p; 95% confidence interval [CI], 3.5 to 8.9) compared to females (1.5%p; 95% CI, −1.2 to 4.1). The age groups with the greatest increases in MetS prevalence after the COVID-19 pandemic were those in their 40s (4.6%p; 95% CI, 0.9 to 8.4) and 50s (5.8%p; 95% CI, 2.2 to 9.4). By educational background, the increase in MetS prevalence was greatest among those with a college degree or higher (5.1%p). The prevalence of MetS in high-income (5.3%p) and low-income (4.6%p) groups significantly increased.
  • CONCLUSIONS
    The increasing trend in the overall prevalence of MetS continued during the COVID-19 pandemic. In particular, the prevalence of MetS among adult males in their 40s and 50s increased significantly after the COVID-19 outbreak in Korea.
  • Keywords: COVID-19, Metabolic syndrome, Social isolation, Pandemics, SARS-CoV-2, Coronavirus
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), capable of causing coronavirus disease 2019 (COVID-19), was first identified in December 2019 but quickly spread worldwide [1], and the World Health Organization (WHO) eventually declared a global pandemic on March 11, 2020 [2]. In the Korea, after the first confirmed case of infection in January 2020, a major epidemic began. Since then, the cumulative number of confirmed COVID-19 cases in Korea exceeded 18,680,000 in July 2022, and >24,700 deaths have been reported [3]. In Korea, varying crisis levels (from 1 to 4) for COVID-19 were implemented, with different degrees of intensity for lockdown orders that encouraged or mandated “social distancing” [4]. The Korean government adjusted the crisis level according to the regional severity of the spread of the disease. Through these response measures, the number of participants in private meetings was limited, access to public facilities became difficult, and nighttime operations were suspended. Students were also unable to attend school and had to study at home via online video classes [5].
The restrictions imposed by the COVID-19 pandemic have fundamentally changed the way people live, affecting their health and behaviors alike [6,7]. Restrictions on outside activities have forced people to stay at home for longer periods of time and increase their sedentary time [8]. An analysis of the Community Health Survey collected by the Korea Disease Control and Prevention Agency in 2020 reported a decrease of 49.6% in physical activity after the spread of SARS-CoV-2 [5]. Screen time, such as time spent watching television, playing online games, and using smartphones, has also increased [9]. Dietary behaviors have also trended negatively, with increased consumption of delivered food, fast food, and snacks [10,11]. These behavioral changes have led to an increased intake of high-calorie and high-fat foods. According to a study by the Korean Society for Obesity, 46% of Koreans gained >3 kg in weight during the COVID-19 pandemic due to reduced physical activity and increased unhealthy irregular eating habits [12]. Negative impacts were also found on mental health. Anxiety, depression, and stress about an uncertain future were exacerbated by prolonged lockdown periods and the contraction of economic activity [13–17]. This deterioration of mental health negatively affected physical activity and eating behaviors, further exacerbating the vicious circle.
Lifestyle changes since the COVID-19 lockdown have increased the prevalence of chronic diseases and obesity [8,18–20]. In a study conducted using Korea National Health and Nutrition Examination Survey (KNHANES) data, the prevalence of obesity, hypertension, diabetes, and hyperlipidemia increased by 6%p, 1.8%p, 1.9%p, and 2.8%p in males during the COVID-19 pandemic, respectively [18]. A study in Italy showed that the prevalence of obesity increased from 37.8% to 51.3% and that of metabolic syndrome (MetS) increased from 14.9% to 27.0% after the initial outbreak of COVID-19 [8]. MetS is a set of risk factors for cardiovascular disease associated with insulin resistance, including abdominal obesity, dyslipidemia, diabetes, and high blood pressure [21]. The prevalence of MetS is on the rise, being mainly associated with obesity and an increase in the number of individuals with sedentary lifestyles [6]. MetS is independently associated with the risk of cardiovascular disease and with cardiovascular mortality [22–26]. Reports have stated that MetS doubled the risk of cardiovascular disease and its associated mortality and stroke [27]. In addition, the presence of MetS was associated with the severity of COVID-19; specifically, a higher number of metabolic components increased the risk of severe COVID-19 linearly [19,28].
In Korea, a study using large-scale national data investigated changes in the prevalence of MetS up to 2018. However, no studies have compared its prevalence before and after the declaration of the COVID-19 pandemic. The purpose of this study was to investigate the impact of COVID-19 on the prevalence of MetS. In addition, we investigated the difference and degree of change in the prevalence of MetS according to demographic characteristics.
Study population
We used data from KNHANES from 2017 to 2020. The KNHANES is a government-designated statistical investigation of the health behaviors of the national population, the prevalence of chronic diseases, and the status of food and nutrition intake in Korea [29]. The subjects of the survey were about 192 survey districts and 23–25 sample households per survey district every year, and all individuals ≥1 year of age were targeted. However, the 2020 survey was suspended as a result of the COVID-19 outbreak, and only 180 survey districts for health surveys and screening surveys and 166 survey districts for nutrition surveys completed their respective surveys. This study included only data from adults ≥19 years of age among the KNHANES data from 2017 to 2020. We compared 2017–2019 as the pre-pandemic period with 2020 as the pandemic period. Pregnant participants were excluded because pregnancy could affect waist circumference regardless of MetS.
Data collection and study variables
The KNHANES investigations are carried out by a specialized investigation team affiliated with the Korea Disease Control and Prevention Agency in mobile examination vehicles. The height and weight of each participant are measured to 1 decimal place using a stadiometer and digital scale. For body mass index (BMI), weight (kg) divided by the square of height (m2) was used. Waist circumference was measured at the mid-point between the lower end of the last rib and the upper end of the iliac crest on the mid-axillary line while the subject was exhaling. Blood pressure was measured 3 times, and the average of the second and third measurements was automatically calculated and recorded. Blood samples were taken and analyzed from participants in fasting conditions for ≥8 hours.
To discern health behaviors, health questionnaire data on drinking, smoking, and physical activity were used. Current smokers were defined as those who had smoked ≥100 cigarettes in their lifetime and still smoked, and current drinkers were defined as those who had drank ≥1 drink per month in the past year. Regarding physical activity, responses were divided into whether or not aerobic physical activity was practiced. Aerobic activity adherence referred to engaging in moderate-intensity physical activity for ≥2.5 hours or engaging in high-intensity physical activity for ≥1 hour and 15 minutes. If a mixture of moderate-intensity physical activity and high-intensity physical activity was performed, 1 minute of high-intensity activity was considered to be the same as 2 minutes of moderate-intensity activity. Diabetes, hypertension, and dyslipidemia were investigated for participants’ medical history and defined according to a self-reported doctor’s diagnosis, regardless of whether a participant took a related drug.
As demographic characteristics, age, sex, marital status, education level, average monthly personal gross income, and occupation were included. The household income group was defined by the value of the equivalized household income quartile. Marital status was divided into single and married, and the married group was further divided into 2 groups: those living with their spouses and those who were separated, widowed, or divorced.
Definition of metabolic syndrome
We defined MetS according to the NCEP-ATP III (modified National Cholesterol Education Program Adult Treatment Panel III) criteria [30]. MetS was diagnosed when ≥3 of the following 5 criteria were met: (1) a waist circumference of ≥90 cm for males or ≥85 cm for females (following Korean-specific cut-offs for abdominal obesity defined by the Korean Society of Obesity [31]), (2) a triglyceride level of ≥150 mg/dL or the use of drugs for this reason; (3) a high-density lipoprotein (HDL) cholesterol level of <40 mg/dL for male or <50 mg/dL for female or taking medications for this reason; (4) a systolic blood pressure (SBP) of ≥130 mmHg, a diastolic blood pressure (DBP) of ≥85 mmHg, or taking anti-hypertensive medications; (5) a fasting blood sugar level of ≥100 mg/dL or taking anti-diabetic medications.
Statistical analysis
All statistical analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA). Changes in MetS prevalence were stratified by sex and age because the effects of the COVID-19 pandemic have been reported to vary according to sex and age. We also performed pre-specified subgroup analyses based on marital status, education level, household income, and occupation. The values for categorical variables were calculated using SAS (PROC SURVEYFREQ; SAS Institute Inc.), and the values for continuous variables were similarly calculated using SAS (PROC SURVEYMEANS; SAS Institute Inc.). If p-value <0.05, the difference was considered to be statistically significant.
Ethics statement
This study was approved by the Institutional Review Board of the Catholic University of Korea, St. Vincent Hospital (IRB approval No. VC22ZISE0119).
General characteristics of subjects
The general characteristics of the KNHANES participants from 2017 to 2020 are described in Table 1. The male-to-female ratio of the participants was 1:1, and the average age was 47–48 years. Participants were found to be evenly distributed in each age group. Alcohol consumption was less (p=0.001) in 2020 than in 2017–2019. Current smoking habits and physical activity also decreased, but without statistical significance. The prevalence rates of diabetes mellitus, hypertension, and dyslipidemia increased to 9.4% (p=0.001), 21.4% (p=0.041), and 18.6% (p=0.001), respectively, after the outbreak of COVID-19. The average BMI was 24.0±0.1 kg/m2 in 2019, which increased to 24.3±0.1 kg/m2 in 2020 (p for trend<0.001). The average hemoglobin A1c was 5.63±0.02% in 2017, which increased gradually to 5.77±0.02% in 2020 (p for trend <0.001). Compared with 2017–2019, fasting glucose also showed an increase in 2020, without statistical significance (p= 0.085). The average total cholesterol level was 190.9±0.6 mg/dL in 2020, which decreased compared to 2017–2019 (p=0.019). The average LDL cholesterol level also decreased to 113.8±1.5mg/dL in 2020 compared to 2017–2019 (p=0.002). The prevalence of MetS increased steadily between 2017 and 2020 (from 29.4 to 35.3%, p for trend <0.001). The annual percent changes (APCs) in prevalence from 2017 to 2020 were 2.0%p, 2.2%p, and 1.7%p, respectively.
Comparison of metabolic syndrome prevalence before and after the COVID-19 pandemic
Figure 1 shows the trends in prevalence according to sex and age groups and the APCs of MetS from 2017 to 2020. The prevalence of MetS steadily increased, and male showed a greater prevalence than female. The prevalence of MetS among male increased notably from 33.4% in 2017 to 41.1% in 2020. The APCs in these males were 1.4%p, 1.8%p, and 4.5%p, respectively, which significantly increased after the COVID-19 outbreak compared to before. In 2017, the prevalence among females was 25.3%, which increased by 2.7%p and 2.6%p every year thereafter. However, after the outbreak of COVID-19, it decreased by −1.1%p, reaching 29.5% in 2020. The prevalence of MetS increased with age each year. The groups with the largest difference in prevalence between 2019 and 2020 were those in their 40s and 50s, who experienced increases of 4.8%p and 2.8%p, respectively. However, the prevalence rates decreased in more advanced age groups (−2.2%p in those 60–69 years old and −0.1%p in those ≥70 years old).
A comparison of the prevalence of MetS in the 3 years before the COVID-19 outbreak and in 2020 after the start of the COVID-19 pandemic is presented in Table 2, and Figure 2 shows a comparison of changes in the prevalence of MetS by age group for males and females, marital status, education level, income, and occupation. The overall prevalence difference was 3.8%p (95% CI, 1.6 to 6.0). The change in prevalence in males was 6.2%p (95% CI, 3.5 to 8.9), which was larger than that in females (1.5%p; 95% CI, −1.2 to 4.1), and the percentage change in females was not statistically significant. The age groups showing the greatest change in prevalence were those in their 40s and 50s, and there was a difference of 4.6%p (95% CI, 0.9 to 8.4) and 5.8%p (95% CI, 2.2 to 9.4), respectively. In males, the change in prevalence was greater in those 40–49 years old (9.6%p; 95% CI, 3.8 to 15.4) and 50–59 years old (10.6%p; 95% CI, 5.1 to 16.1). The prevalence also increased by 6.1%p (95% CI, 0.6 to 11.6) in those 70 years and older. In females, there were no statistically significant changes in prevalence according to age group.
When looking at the change in the prevalence of MetS after the outbreak of COVID-19 according to marital status, it was highest in both unmarried and married couples living together at 4.2%p (95% CI, 1.2 to 7.3 and 1.6 to 6.9, respectively). The prevalence was found to increase by 3.3%p in the separated, divorced, or widowed group, but the change was not statistically significant. The change in prevalence was 5.1%p (95% CI, 3.1 to 7.2) with the largest shift occurring in those who had graduated college or higher compared to those with less education. According to household income, the smallest change was found in the low-middle group (0.9%p; 95% CI, −2.6 to 4.4), and this change was not statistically significant. The change in prevalence was largest in the high-income group at 5.3%p (95% CI, 1.8 to 8.8), followed by the low-income group at 4.6%p (95% CI, 0.8 to 8.4). Among occupations, engineers, technicians, and assemblers showed the greatest change in prevalence, at 5.6%p (95% CI, 0.1 to 11.1).
This study observed changes in the prevalence of MetS after social distancing measures were implemented due to the COVID-19 pandemic using large-scale Korean national data. From 2017 to 2020, the prevalence of MetS showed a steadily increasing trend. The prevalence of MetS in 2020 significantly increased compared to the average of the 3 years prior to the COVID-19 pandemic. In particular, the increase in prevalence was remarkable among males in their 40s and 50s.
According to a systematic review from 2017, in most countries, ≥20% of the adult population has been identified to have MetS, and this prevalence is gradually increasing [32]. In Korea, a fact sheet using KNHANES data from 2007 to 2018 was published [6], and the prevalence of MetS was almost constant from 2007 to 2014, then gradually began increasing after 2015. In this study, as in the previous study, the prevalence of MetS showed a tendency to increase. However, between 2019 and 2020—that is, before and after the COVID-19 outbreak—the overall APC did not significantly differ from previous APCs. This is because, between 2019 and 2020, the prevalence of MetS among males increased significantly by 4.5%p, while it decreased among females by 0.9%p.
When we compared the characteristics of the participants between 2017–2019 and 2020, the prevalence rates of diabetes, hypertension, and dyslipidemia also increased statistically significantly. In addition, the BMI was also observed to have increased. After the outbreak of COVID-19, these changes inevitably led to a rise in the prevalence of MetS, which was greatest in males in their 50s after the COVID-19 outbreak, followed by males in their 40s. The significant increase in the prevalence of MetS among males in their 40s and 50s appears to have been due to increased sedentary lifestyles, economic difficulties, and stress [6,18,29,33,34]. According to the Economically Active Population Census administered by the National Statistical Office of Korea [35], the labor force participation rate in 2020 was 77.9% for males versus 59.1% for females. In addition, in 2020 compared to 2019, the labor force participation rate decreased from 69.5% to 68.6%, and the unemployment rate increased from 3.8% to 4.0%. Males with a high labor force participation rate are more likely to have been exposed to psychological stress and the effects of increased sedentary lifestyles due to telecommuting. This would have made them more susceptible to dietary pattern changes and increased BMI values. A characteristic feature of the APC of MetS prevalence by age group during 2017–2020 is that the prevalence of MetS in the population aged 60 years, which had been on the rise, decreased after the COVID-19 outbreak. It seems that the younger generation suffered the most from the COVID-19 crisis. Younger people had more reduced levels of physical activity, were more likely to be stressed, and were more likely to drink excessively than older people. They were also more likely to eat delivery food as part of an unhealthy diet. After the COVID-19 pandemic, young people ≤40 years of age had negative changes in ≥1 health behaviors, while older people >70 years of age had positive changes [5]. The elderly population seems now to be more concerned about their health than before the outbreak of COVID-19 and made efforts to make positive changes to their lifestyle [34].
Unmarried people are younger and more likely to be economically active than those in other marital statuses. Depression in the COVID-19 era was confirmed to be more severe at younger ages [36], probably due to social isolation, loneliness, and uncertainty about the future. The relationship between depression and MetS has also been confirmed through a meta-analysis [37]. Those who are married and living together may have felt greater responsibility for their families due to the economic uncertainty and crisis following the COVID-19 outbreak. Furthermore, in some cases, as the whole family spends more time at home, conflicts within the family have increased. These changes increased stress and may have contributed to the increase in the prevalence of MetS. The change in the prevalence of MetS was greatest in those with a college degree or higher, probably because people with higher educational levels spend more time sitting and engage in less physical activity [5,38]. During the COVID-19 lockdown period, they may have been working sedentary, using computers for more hours than before. These would lead to unhealthy eating habits [5,39]. Most people with high incomes have a high level of education. Therefore, they also tend to lead a sedentary lifestyle because they are more likely to work at a desk. These sedentary lifestyles may have contributed to an increase in obesity and MetS prevalence [40]. In contrast, those with low income would have been most vulnerable to anxiety and stress as they were greatly exposed to economic uncertainty caused by rising unemployment, declining income, and financial difficulties [13,14].
There are several limitations to this study. First, as this study was not a longitudinal study of the same subjects, its findings do not provide definitive support for a causal relationship. Second, after the outbreak of COVID-19, Korea announced an active response policy from February 23, 2020, and since KNHANES data were steadily collected from January to December 2020, the periodical impact of social isolation may vary among subjects. Finally, since the KNHANES data in 2020 were collected within a short period of time after the outbreak of COVID-19, the increase in the prevalence of MetS cannot be confirmed to have been due to the impact of the COVID-19 lockdown. Furthermore, the available data to date are limited to 2020 and earlier, and there has been insufficient research into the impact of the COVID-19 lockdown period beyond 2021. However, this study is meaningful in that it observed changes in the prevalence of MetS in Koreans during the COVID-19 pandemic using objective measurement results obtained according to a standardized protocol using large-scale national data. This study also makes a meaningful contribution by providing information on groups with large changes in MetS prevalence after the COVID-19 outbreak.
In conclusion, the prevalence of MetS has increased steadily since 2017 and has continued to increase following the outbreak of COVID-19. In particular, efforts are needed to improve the lifestyle of males in their 40s and 50s, which is a group that experienced a significant increase in the prevalence of MetS. Even after 2021, as the COVID-19 pandemic continues and the period of social isolation becomes longer, it is necessary to continue observing trends in these changes.
Statistical consultation was supported by the Department of Biostatistics of the Catholic Research Coordinating Center.

CONFLICT OF INTEREST

The authors have no conflicts of interest to declare for this study.

AUTHOR CONTRIBUTIONS

Both authors contributed equally to conceiving the study, analyzing the data, and writing this paper.

FUNDING

None.

Figure 1
Trends in the prevalence of metabolic syndrome from 2017 to 2020 by sex (A) and age group (B).
epih-44-e2022101f1.jpg
Figure 2
Differences in the prevalence of metabolic syndrome between 2017–2019 and 2020 according to age group in males (A), age group in females (B), marital status (C), education (D), household income (E), and occupation (F).
epih-44-e2022101f2.jpg
epih-44-e2022101f3.jpg
Table 1.
General characteristics of the KNHANES participants from 2017 to 2020
Characteristics Total (n=24,564) 2017 (n=6,167) 2018 (n=6,216) 2019 (n=6,269) 2020 (n=5,912) p-value (2017-2019) vs. 2020 p for trend
Sex 0.696 0.800
Male 10,931 (50.0) 2,749 (50.0) 2,736 (50.1) 2,795 (50.0) 2,651 (50.0)
Female 13,633 (50.0) 3,418 (50.0) 3,480 (49.9) 3,474 (50.0) 3,261 (50.0)
Age (yr) 47.8±0.2 47.4±0.5 47.6±0.4 48.0±0.5 48.3±0.5 0.262 0.122
19-29 3,030 (17.5) 724 (17.5) 759 (17.8) 749 (17.4) 798 (17.3) 0.558 0.118
30-39 3,462 (17.0) 893 (17.6) 899 (17.2) 907 (16.8) 763 (16.5)
40-49 4,368 (19.7) 1,138 (20.5) 1,134 (20.0) 1,124 (19.4) 972 (19.1)
50-59 4,664 (20.0) 1,215 (20.0) 1,198 (19.9) 1,186 (20.0) 1,065 (19.8)
60-69 4,469 (13.9) 1,101 (13.0) 1,109 (13.5) 1,135 (14.2) 1,124 (14.9)
≥70 4,571 (12.0) 1,096 (11.4) 1,117 (11.8) 1,168 (12.2) 1,190 (12.6)
Alcohol use, current 0.001 <0.001
No 8,608 (36.9) 2,062 (34.6) 2,210 (36.9) 2,155 (36.5) 2,175 (39.3)
Yes 12,931 (63.1) 3,325 (65.4) 3,315 (63.1) 3,322 (63.5) 2,969 (60.7)
Smoking, current 0.063 0.053
No 19,972 (79.4) 4,995 (78.8) 5,029 (78.5) 5,081 (79.6) 4,867 (80.6)
Yes 4,289 (20.6) 1,094 (21.2) 1,132 (21.5) 1,082 (20.4) 981 (19.4)
Aerobic activity adherence 0.156 0.133
No 13,239 (54.7) 3,301 (53.5) 3,469 (55.1) 3,343 (54.3) 3,126 (56.0)
Yes 9,764 (45.3) 2,483 (46.5) 2,471 (44.9) 2,548 (45.7) 2,262 (44.0)
Medical history 0.001 0.002
DM 2,477 (8.1) 596 (7.5) 574 (7.3) 624 (8.2) 683 (9.4)
HBP 6,152 (20.0) 1,482 (18.5) 1,491 (19.2) 1,609 (20.8) 1,570 (21.4) 0.041 0.003
Dyslipidemia 4,900 (16.8) 1,167 (16.2) 1,198 (15.7) 1,221 (16.5) 1,314 (18.6) 0.001 0.003
Marital status 0.169 0.426
Single 4,385 (23.9) 1,037 (23.4) 1,096 (24.0) 1,079 (23.0) 1,173 (25.4)
Married (cohabitation) 16,555 (64.9) 4,236 (65.7) 4,220 (64.5) 4,283 (66.2) 3,816 (63.2)
Divorced/Widowed/Separated 3,608 (11.2) 890 (10.9) 897 (11.5) 905 (10.8) 916 (11.4)
Education 0.054 0.040
≤Middle school 6,211 (19.5) 1,723 (21.8) 1,620 (20.3) 1,540 (18.8) 1,328 (17.1)
High school 6,301 (27.7) 1,502 (25.7) 1,657 (28.4) 1,643 (28.2) 1,499 (28.6)
≥College 10,511 (52.7) 2,569 (52.4) 2,664 (51.4) 2,712 (53.0) 2,566 (54.3)
Household income 0.841 0.466
Low 6,108 (25.1) 1,535 (25.2) 1,547 (26.0) 1,565 (24.6) 1,461 (24.5)
Low-middle 6,135 (25.0) 1,549 (24.8) 1,557 (25.9) 1,556 (24.9) 1,473 (24.6)
Middle-high 6,098 (25.1) 1,512 (24.9) 1,550 (24.7) 1,564 (25.6) 1,472 (25.4)
High 6,116 (24.8) 1,546 (25.1) 1,541 (23.4) 1,550 (25.0) 1,479 (25.5)
Occupation 0.571 0.228
Administrators and specialists 3,316 (16.5) 848 (17.1) 895 (17.0) 809 (15.8) 764 (16.2)
Office worker 2,482 (12.3) 64 8(12.8) 611 (11.6) 668 (12.9) 555 (11.7)
Service workers and marketers 2,978 (13.9) 660 (12.1) 843 (15.4) 736 (13.7) 739 (14.4)
Agriculture, forestry, and fishery 869 (2.6) 279 (3.3) 228 (2.7) 175 (2.1) 187 (2.4)
Engineers, technicians, and assemblers 2,308 (11.6) 585 (11.9) 609 (12.1) 614 (11.9) 500 (10.6)
Manual laborers 2,052 (7.9) 501 (7.9) 506 (7.3) 554 (8.1) 491 (8.0)
Homemakers and students 8,974 (35.2) 2,271 (35.0) 2,238 (33.9) 2,320 (35.5) 2,145 (36.7)
BMI (kg/m2) 24.0±0.0 23.9±0.1 24.0±0.1 24.0±0.1 24.3±0.1 <0.001 <0.001
Obesity (BMI ≥25 kg/m2) <0.001 0.003
No 15,757 (64.4) 4,004 (65.3) 4,029 (65.0) 4,110 (65.6) 3,614 (61.6)
Yes 8,615 (35.7) 2,148 (34.7) 2,142 (35.0) 2,123 (34.4) 2,202 (38.4)
Waist circumference (cm) 83.1±0.1 81.7±0.2 82.2±0.2 83.8±0.2 84.7±0.2 <0.001 <0.001
Systolic BP (mmHg) 118.0±0.2 117.5±0.4 117.8±0.4 118.5±0.3 118.3±0.4 0.426 0.053
Diastolic BP (mmHg) 76.0±0.1 75.8±0.2 76.0±0.2 76.0±0.2 76.1±0.2 0.414 0.271
HbA1c (%) 5.70±0.01 5.63±0.02 5.65±0.01 5.75±0.01 5.77±0.02 <0.001 <0.001
Fasting glucose (mg/dL) 100.4±0.2 99.8±0.4 100.2±0.3 100.5±0.4 101.0±0.4 0.085 0.027
Total cholesterol (mg/dL) 192.1±0.3 193.2±0.7 191.7±0.7 192.8±0.6 190.9±0.6 0.019 0.039
Triglycerides (mg/dL) 135.1±0.9 135.7±1.8 136.2±1.8 131.8±1.7 136.7±2.2 0.368 0.900
LDL-cholesterol (mg/dL) 117.7±0.8 121.1±1.6 117.9±1.4 118.4±1.5 113.8±1.5 0.002 0.002
HDL-cholesterol (mg/dL) 51.6±0.1 51.1±0.2 51.0±0.3 52.7±0.3 51.4±0.2 0.536 0.005
Metabolic syndrome 8,910 (32.4) 2,069 (29.4) 2,185 (31.4) 2,316 (33.6) 2,340 (35.3) 0.001 <0.001

Values are presented as number (weighted %) or mean±standard error.

KNEANES, Korea National Health and Nutritional Examination Survey; DM, diabetes mellitus; HBP, high blood pressure; BP, blood pressure, BMI, body mass index; LDL, low-density lipoprotein; HDL, high-density lipoprotein.

Table 2.
Changes in the prevalence of metabolic syndrome in 2020 compared to 3 years before the COVID-19 pandemic
Variables 2017-2019 2020 Changes
Difference (%p) 95% CI
LL UL
Total, age ≥19 (yr) 31.5 (30.5, 32.4) 35.3 (33.4, 37.1) 3.8 1.6 6.0
19-29 8.4 (7.1, 9.8) 10.2 (8.0, 12.3) 1.7 -0.9 4.3
30-39 18.0 (16.3, 19.7) 20.5 (16.8, 24.2) 2.5 -1.6 6.5
40-49 26.9 (25.1, 28.7) 31.5 (28.2, 34.8) 4.6 0.9 8.4
50-59 37.6 (35.8, 39.5) 43.4 (40.3, 46.4) 5.8 2.2 9.4
60-69 51.5 (49.5, 53.5) 52.4 (48.1, 56.6) 0.9 -3.9 5.6
≥70 59.7 (57.7, 61.6) 61.7 (58.5, 64.9) 2.1 -1.7 5.8
Male, age ≥19 (yr) 34.9 (33.7, 36.2) 41.1 (38.7, 43.5) 6.2 3.5 8.9
19-29 11.6 (9.4, 13.9) 13.2 (9.6, 16.7) 1.5 -2.6 5.7
30-39 26.2 (23.5, 28.8) 28.5 (23.0, 34.1) 2.4 -3.8 8.5
40-49 37.9 (35.1, 40.7) 47.5 (42.4, 52.6) 9.6 3.8 15.4
50-59 44.8 (42.1, 47.5) 55.4 (50.6, 60.1) 10.6 5.1 16.1
60-69 50.3 (47.5, 53.0) 52.7 (46.7, 58.7) 2.5 -4.2 9.1
≥70 49.4 (46.5, 52.4) 55.5 (50.8, 60.2) 6.1 0.6 11.6
Female, age ≥19 (yr) 28.0 (26.8, 29.2) 29.5 (27.2, 31.7) 1.5 -1.2 4.1
19-29 4.8 (3.3, 6.2) 6.9 (4.2, 9.5) 2.1 -1.0 5.1
30-39 8.8 (7.0, 10.5) 11.5 (7.7, 15.3) 2.7 -1.5 7.0
40-49 15.5 (13.6, 17.4) 14.8 (11.3, 18.4) -0.7 -4.7 3.3
50-59 30.4 (28.1, 32.7) 31.3 (27.0, 35.7) 0.9 -4.1 5.9
60-69 52.7 (50.0, 55.4) 52.0 (47.3, 56.7) -0.7 -6.2 4.8
≥70 66.6 (64.2, 68.9) 66.0 (61.8, 70.3) -0.5 -5.4 4.3
Marital status
Single 13.7 (12.2, 15.2) 17.9 (15.3, 20.6) 4.2 1.2 7.3
Married (cohabitation) 34.7 (33.5, 35.8) 38.9 (36.6, 41.2) 4.2 1.6 6.9
Divorced/Widowed/Separated 50.3 (48.0, 52.5) 53.5 (49.6, 57.5) 3.3 -1.3 7.8
Education
≤Middle school 55.0 (53.4, 56.7) 57.6 (53.7, 61.4) 2.5 -1.7 6.8
High school 34.3 (32.7, 35.9) 36.7 (33.4, 39.9) 2.3 -1.3 5.9
≥College 20.6 (19.6, 21.6) 25.7 (23.9, 27.5) 5.1 3.1 7.2
Household income
Low 33.6 (31.9, 35.3) 38.2 (34.8, 41.5) 4.6 0.8 8.4
Low-middle 32.3 (30.6, 34.0) 33.2 (30.2, 36.2) 0.9 -2.6 4.4
Middle-high 31.2 (29.6, 32.8) 35.8 (32.8, 38.9) 4.6 1.2 8.1
High 28.7 (27.0, 30.3) 34.0 (30.9, 37.0) 5.3 1.8 8.8
Occupation
Administrators and specialists 22.9 (21.2, 24.7) 26.8 (23.7, 29.9) 3.9 0.3 7.5
Office worker 24.3 (22.0, 26.6) 29.3 (24.6, 33.9) 5.0 -0.3 10.2
Service workers and marketers 28.8 (26.7, 31.0) 33.6 (29.3, 38.0) 4.8 0.0 9.7
Agriculture, forestry, and fishery 51.5 (46.6, 56.5) 47.7 (34.7, 60.7) -3.8 -17.8 10.1
Engineers, technicians, and assemblers 34.9 (32.3, 37.5) 40.5 (35.6, 45.3) 5.6 0.1 11.1
Manual laborers 38.3 (35.4, 41.3) 39.3 (34.3, 44.3) 1.0 -4.9 6.9
Homemakers and students 34.7 (33.2, 36.3) 35.9 (33.3, 38.5) 1.2 -2.0 4.3

Values are presented as weighted % (95% CI).

COVID-19, coronavirus disease 2019; CI, confidence interval; %p, percentage points; LL, lower limit; UL, upper limit.

  • 1. World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. [cited 2022 Jul 15]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it .
  • 2. World Health Organization. Coronavirus disease (COVID-19) pandemic. [cited 2022 Jul 15]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 .
  • 3. Ministry of Health and Welfare. Coronavirus (COVID-19). Republic of Korea; [cited 2022 Jul 15]. Available from: http://ncov.mohw.go.kr/en/ .
  • 4. Kwon JY, Song SW, Kim HN, Kang SG. Changes in body mass index and prevalence of metabolic syndrome during COVID-19 lockdown period. Korean J Fam Pract 2021;11:304-311 Korean.Article
  • 5. Mun H, So ES. Changes in physical activity, healthy diet, and sleeping time during the COVID-19 pandemic in South Korea. Nutrients 2022;14:960.ArticlePubMedPMC
  • 6. Huh JH, Kang DR, Kim JY, Koh KK. Taskforce Team of the Metabolic Syndrome Fact Sheet of the Korean Society of Cardiometabolic Syndrome. Metabolic syndrome fact sheet 2021: executive report. Cardiometab Syndr J 2021;1:125-134.ArticlePDF
  • 7. Kang E, Lee H, Sohn JH, Yun J, Lee JY, Hong YC. Impact of the COVID-19 pandemic on the health status and behaviors of adults in Korea: national cross-sectional web-based self-report survey. JMIR Public Health Surveill 2021;7:e31635.ArticlePubMedPMC
  • 8. Auriemma RS, Pirchio R, Liccardi A, Scairati R, Del Vecchio G, Pivonello R, et al. Metabolic syndrome in the era of COVID-19 outbreak: impact of lockdown on cardiometabolic health. J Endocrinol Invest 2021;44:2845-2847.ArticlePubMedPMCPDF
  • 9. Kirwan R, McCullough D, Butler T, Perez de Heredia F, Davies IG, Stewart C. Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss. Geroscience 2020;42:1547-1578.ArticlePubMedPMCPDF
  • 10. Lim S, Lim H, Després JP. Collateral damage of the COVID-19 pandemic on nutritional quality and physical activity: perspective from South Korea. Obesity (Silver Spring) 2020;28:1788-1790.ArticlePubMedPMCPDF
  • 11. Naja F, Hamadeh R. Nutrition amid the COVID-19 pandemic: a multi-level framework for action. Eur J Clin Nutr 2020;74:1117-1121.ArticlePubMedPMCPDF
  • 12. Korean Society for the Study of Obesity. People’s weight management status and obesity awareness in the COVID-19 era. [cited 2022 Jul 15]. Available from: http://general.kosso.or.kr/html/?pmode=BBBS0001300004&smode=view&seq=1372 (Korean)..
  • 13. Statistics Korea. December 2020 and annual employment trend. 2021 [cited 2022 Jul 15]. Available from: http://kostat.go.kr/portal/korea/kor_nw/1/1/index.board?bmode=read&aSeq=387733 (Korean)..
  • 14. Altig D, Baker S, Barrero JM, Bloom N, Bunn P, Chen S, et al. Economic uncertainty before and during the COVID-19 pandemic. J Public Econ 2020;191:104274.ArticlePubMedPMC
  • 15. Fukase Y, Ichikura K, Murase H, Tagaya H. Depression, risk factors, and coping strategies in the context of social dislocations resulting from the second wave of COVID-19 in Japan. BMC Psychiatry 2021;21:33.ArticlePubMedPMCPDF
  • 16. Kim JW, Stewart R, Kang SJ, Jung SI, Kim SW, Kim JM. Telephone based Interventions for psychological problems in hospital isolated patients with COVID-19. Clin Psychopharmacol Neurosci 2020;18:616-620.ArticlePubMedPMC
  • 17. Jeong H, Park S, Kim J, Oh K, Yim HW. Mental health of Korean adults before and during the COVID-19 pandemic: a special report of the 2020 Korea National Health and Nutrition Examination Survey. Epidemiol Health 2022;44:e2022042.ArticlePubMedPMC
  • 18. Lee GB, Kim Y, Park S, Kim HC, Oh K. Obesity, hypertension, diabetes mellitus, and hypercholesterolemia in Korean adults before and during the COVID-19 pandemic: a special report of the 2020 Korea National Health and Nutrition Examination Survey. Epidemiol Health 2022;44:e2022041.ArticlePubMedPMC
  • 19. Martinez-Ferran M, de la Guía-Galipienso F, Sanchis-Gomar F, Pareja-Galeano H. Metabolic impacts of confinement during the COVID-19 pandemic due to modified diet and physical activity habits. Nutrients 2020;12:1549.ArticlePubMedPMC
  • 20. Hur YI, Huh Y, Lee JH, Lee CB, Kim BY, Yu SH, et al. Factors associated with body weight gain among Korean adults during the COVID-19 pandemic. J Obes Metab Syndr 2022;31:51-60.ArticlePubMedPMC
  • 21. Kahn R, Buse J, Ferrannini E, Stern M. American Diabetes Association; European Association for the Study of Diabetes. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289-2304.ArticlePubMedPDF
  • 22. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005;28:385-390.ArticlePubMedPDF
  • 23. Kazlauskienė L, Butnorienė J, Norkus A. Metabolic syndrome related to cardiovascular events in a 10-year prospective study. Diabetol Metab Syndr 2015;7:102.PubMedPMC
  • 24. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005;28:1769-1778.PubMed
  • 25. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007;49:403-414.PubMed
  • 26. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006;119:812-819.ArticlePubMed
  • 27. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010;56:1113-1132.PubMed
  • 28. Cho DH, Choi J, Gwon JG. Metabolic syndrome and the risk of COVID-19 infection: a nationwide population-based case-control study. Nutr Metab Cardiovasc Dis 2021;31:2596-2604.ArticlePubMedPMC
  • 29. Oh K, Kim Y, Kweon S, Kim S, Yun S, Park S, et al. Korea National Health and Nutrition Examination Survey, 20th anniversary: accomplishments and future directions. Epidemiol Health 2021;43:e2021025.ArticlePubMedPMC
  • 30. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.ArticlePubMed
  • 31. Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 2007;75:72-80.ArticlePubMed
  • 32. Ranasinghe P, Mathangasinghe Y, Jayawardena R, Hills AP, Misra A. Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review. BMC Public Health 2017;17:101.ArticlePubMedPMCPDF
  • 33. Choi S, Bahk J, Park S, Oh K, Jung-Choi K. Smoking, drinking, and physical activity among Korean adults before and during the COVID-19 pandemic: a special report of the 2020 Korea National Health and Nutrition Examination Survey. Epidemiol Health 2022;44:e2022043.ArticlePubMedPMC
  • 34. Rha JY, Lee B, Nam Y, Yoon J. COVID-19 and changes in Korean consumers’ dietary attitudes and behaviors. Nutr Res Pract 2021;15(Suppl 1):S94-S109.ArticlePubMedPMCPDF
  • 35. Statistics Korea. Economically active population census. [cited 2022 Aug 2]. Available from: https://www.index.go.kr/unity/potal/main/EachDtlPageDetail.do?idx_cd=1494 (Korean)..
  • 36. Kim SW, Park IH, Kim M, Park AL, Jhon M, Kim JW, et al. Risk and protective factors of depression in the general population during the COVID-19 epidemic in Korea. BMC Psychiatry 2021;21:445.ArticlePubMedPMCPDF
  • 37. Ghanei Gheshlagh R, Parizad N, Sayehmiri K. The relationship between depression and metabolic syndrome: systematic review and meta-analysis study. Iran Red Crescent Med J 2016;18:e26523.ArticlePubMedPMC
  • 38. Lee Y, Baek S, Shin J. Changes in physical activity compared to the situation before the outbreak of COVID-19 in Korea. Int J Environ Res Public Health 2021;19:126.ArticlePubMedPMC
  • 39. Nishitani N, Sakakibara H. Relationship of obesity to job stress and eating behavior in male Japanese workers. Int J Obes (Lond) 2006;30:528-533.ArticlePubMedPDF
  • 40. Hwang WJ, Lee CY. Effect of psychosocial factors on metabolic syndrome in male and female blue-collar workers. Jpn J Nurs Sci 2014;11:23-34.ArticlePubMed

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • Deep autoencoders and multivariate analysis for enhanced hypertension detection during the COVID-19 era
      Khongorzul Dashdondov, Mi-Hye Kim, Mi-Hwa Song
      Electronic Research Archive.2024; 32(5): 3202.     CrossRef
    • Metabolic Syndrome Prevalence Change Before and After the COVID-19 Epidemic: Using Data from the National Health and Nutrition Examination Survey 2018-2021
      Jung-Hwa Kim, Kyung-Hee Kim, Gyu Bin Park, Won Kee Lee
      Journal of Health Informatics and Statistics.2024; 49(4): 315.     CrossRef
    • Increasing incidence and prevalence of metabolic syndrome in people living with HIV during the COVID-19 pandemic
      Rebecka Papaioannu Borjesson, Laura Galli, Camilla Muccini, Andrea Poli, Tommaso Clemente, Martina Bottanelli, Nicola Gianotti, Silvia Nozza, Antonella Castagna, Vincenzo Spagnuolo
      Frontiers in Medicine.2023;[Epub]     CrossRef
    • Body mass index and prevalence of metabolic syndrome among Korean adults before and after the COVID-19 outbreak: a retrospective longitudinal study
      Joo-Eun Jeong, Hoon-Ki Park, Hwan-Sik Hwang, Kye-Yeung Park, Myoung-Hye Lee, Seon-Hi Shin, Nayeon Choi
      Epidemiology and Health.2023; 45: e2023081.     CrossRef

    • PubReader PubReader
    • Cite
      CITE
      export Copy
      Close
    • XML DownloadXML Download
    Figure
    • 0
    • 1
    • 2
    Related articles
    Changes in the prevalence of metabolic syndrome in Korean adults after the COVID-19 outbreak
    Image Image Image
    Figure 1 Trends in the prevalence of metabolic syndrome from 2017 to 2020 by sex (A) and age group (B).
    Figure 2 Differences in the prevalence of metabolic syndrome between 2017–2019 and 2020 according to age group in males (A), age group in females (B), marital status (C), education (D), household income (E), and occupation (F).
    Graphical abstract

    Figure 1

    Figure 2

    Graphical abstract

    Changes in the prevalence of metabolic syndrome in Korean adults after the COVID-19 outbreak
    Characteristics Total (n=24,564) 2017 (n=6,167) 2018 (n=6,216) 2019 (n=6,269) 2020 (n=5,912) p-value (2017-2019) vs. 2020 p for trend
    Sex 0.696 0.800
    Male 10,931 (50.0) 2,749 (50.0) 2,736 (50.1) 2,795 (50.0) 2,651 (50.0)
    Female 13,633 (50.0) 3,418 (50.0) 3,480 (49.9) 3,474 (50.0) 3,261 (50.0)
    Age (yr) 47.8±0.2 47.4±0.5 47.6±0.4 48.0±0.5 48.3±0.5 0.262 0.122
    19-29 3,030 (17.5) 724 (17.5) 759 (17.8) 749 (17.4) 798 (17.3) 0.558 0.118
    30-39 3,462 (17.0) 893 (17.6) 899 (17.2) 907 (16.8) 763 (16.5)
    40-49 4,368 (19.7) 1,138 (20.5) 1,134 (20.0) 1,124 (19.4) 972 (19.1)
    50-59 4,664 (20.0) 1,215 (20.0) 1,198 (19.9) 1,186 (20.0) 1,065 (19.8)
    60-69 4,469 (13.9) 1,101 (13.0) 1,109 (13.5) 1,135 (14.2) 1,124 (14.9)
    ≥70 4,571 (12.0) 1,096 (11.4) 1,117 (11.8) 1,168 (12.2) 1,190 (12.6)
    Alcohol use, current 0.001 <0.001
    No 8,608 (36.9) 2,062 (34.6) 2,210 (36.9) 2,155 (36.5) 2,175 (39.3)
    Yes 12,931 (63.1) 3,325 (65.4) 3,315 (63.1) 3,322 (63.5) 2,969 (60.7)
    Smoking, current 0.063 0.053
    No 19,972 (79.4) 4,995 (78.8) 5,029 (78.5) 5,081 (79.6) 4,867 (80.6)
    Yes 4,289 (20.6) 1,094 (21.2) 1,132 (21.5) 1,082 (20.4) 981 (19.4)
    Aerobic activity adherence 0.156 0.133
    No 13,239 (54.7) 3,301 (53.5) 3,469 (55.1) 3,343 (54.3) 3,126 (56.0)
    Yes 9,764 (45.3) 2,483 (46.5) 2,471 (44.9) 2,548 (45.7) 2,262 (44.0)
    Medical history 0.001 0.002
    DM 2,477 (8.1) 596 (7.5) 574 (7.3) 624 (8.2) 683 (9.4)
    HBP 6,152 (20.0) 1,482 (18.5) 1,491 (19.2) 1,609 (20.8) 1,570 (21.4) 0.041 0.003
    Dyslipidemia 4,900 (16.8) 1,167 (16.2) 1,198 (15.7) 1,221 (16.5) 1,314 (18.6) 0.001 0.003
    Marital status 0.169 0.426
    Single 4,385 (23.9) 1,037 (23.4) 1,096 (24.0) 1,079 (23.0) 1,173 (25.4)
    Married (cohabitation) 16,555 (64.9) 4,236 (65.7) 4,220 (64.5) 4,283 (66.2) 3,816 (63.2)
    Divorced/Widowed/Separated 3,608 (11.2) 890 (10.9) 897 (11.5) 905 (10.8) 916 (11.4)
    Education 0.054 0.040
    ≤Middle school 6,211 (19.5) 1,723 (21.8) 1,620 (20.3) 1,540 (18.8) 1,328 (17.1)
    High school 6,301 (27.7) 1,502 (25.7) 1,657 (28.4) 1,643 (28.2) 1,499 (28.6)
    ≥College 10,511 (52.7) 2,569 (52.4) 2,664 (51.4) 2,712 (53.0) 2,566 (54.3)
    Household income 0.841 0.466
    Low 6,108 (25.1) 1,535 (25.2) 1,547 (26.0) 1,565 (24.6) 1,461 (24.5)
    Low-middle 6,135 (25.0) 1,549 (24.8) 1,557 (25.9) 1,556 (24.9) 1,473 (24.6)
    Middle-high 6,098 (25.1) 1,512 (24.9) 1,550 (24.7) 1,564 (25.6) 1,472 (25.4)
    High 6,116 (24.8) 1,546 (25.1) 1,541 (23.4) 1,550 (25.0) 1,479 (25.5)
    Occupation 0.571 0.228
    Administrators and specialists 3,316 (16.5) 848 (17.1) 895 (17.0) 809 (15.8) 764 (16.2)
    Office worker 2,482 (12.3) 64 8(12.8) 611 (11.6) 668 (12.9) 555 (11.7)
    Service workers and marketers 2,978 (13.9) 660 (12.1) 843 (15.4) 736 (13.7) 739 (14.4)
    Agriculture, forestry, and fishery 869 (2.6) 279 (3.3) 228 (2.7) 175 (2.1) 187 (2.4)
    Engineers, technicians, and assemblers 2,308 (11.6) 585 (11.9) 609 (12.1) 614 (11.9) 500 (10.6)
    Manual laborers 2,052 (7.9) 501 (7.9) 506 (7.3) 554 (8.1) 491 (8.0)
    Homemakers and students 8,974 (35.2) 2,271 (35.0) 2,238 (33.9) 2,320 (35.5) 2,145 (36.7)
    BMI (kg/m2) 24.0±0.0 23.9±0.1 24.0±0.1 24.0±0.1 24.3±0.1 <0.001 <0.001
    Obesity (BMI ≥25 kg/m2) <0.001 0.003
    No 15,757 (64.4) 4,004 (65.3) 4,029 (65.0) 4,110 (65.6) 3,614 (61.6)
    Yes 8,615 (35.7) 2,148 (34.7) 2,142 (35.0) 2,123 (34.4) 2,202 (38.4)
    Waist circumference (cm) 83.1±0.1 81.7±0.2 82.2±0.2 83.8±0.2 84.7±0.2 <0.001 <0.001
    Systolic BP (mmHg) 118.0±0.2 117.5±0.4 117.8±0.4 118.5±0.3 118.3±0.4 0.426 0.053
    Diastolic BP (mmHg) 76.0±0.1 75.8±0.2 76.0±0.2 76.0±0.2 76.1±0.2 0.414 0.271
    HbA1c (%) 5.70±0.01 5.63±0.02 5.65±0.01 5.75±0.01 5.77±0.02 <0.001 <0.001
    Fasting glucose (mg/dL) 100.4±0.2 99.8±0.4 100.2±0.3 100.5±0.4 101.0±0.4 0.085 0.027
    Total cholesterol (mg/dL) 192.1±0.3 193.2±0.7 191.7±0.7 192.8±0.6 190.9±0.6 0.019 0.039
    Triglycerides (mg/dL) 135.1±0.9 135.7±1.8 136.2±1.8 131.8±1.7 136.7±2.2 0.368 0.900
    LDL-cholesterol (mg/dL) 117.7±0.8 121.1±1.6 117.9±1.4 118.4±1.5 113.8±1.5 0.002 0.002
    HDL-cholesterol (mg/dL) 51.6±0.1 51.1±0.2 51.0±0.3 52.7±0.3 51.4±0.2 0.536 0.005
    Metabolic syndrome 8,910 (32.4) 2,069 (29.4) 2,185 (31.4) 2,316 (33.6) 2,340 (35.3) 0.001 <0.001
    Variables 2017-2019 2020 Changes
    Difference (%p) 95% CI
    LL UL
    Total, age ≥19 (yr) 31.5 (30.5, 32.4) 35.3 (33.4, 37.1) 3.8 1.6 6.0
    19-29 8.4 (7.1, 9.8) 10.2 (8.0, 12.3) 1.7 -0.9 4.3
    30-39 18.0 (16.3, 19.7) 20.5 (16.8, 24.2) 2.5 -1.6 6.5
    40-49 26.9 (25.1, 28.7) 31.5 (28.2, 34.8) 4.6 0.9 8.4
    50-59 37.6 (35.8, 39.5) 43.4 (40.3, 46.4) 5.8 2.2 9.4
    60-69 51.5 (49.5, 53.5) 52.4 (48.1, 56.6) 0.9 -3.9 5.6
    ≥70 59.7 (57.7, 61.6) 61.7 (58.5, 64.9) 2.1 -1.7 5.8
    Male, age ≥19 (yr) 34.9 (33.7, 36.2) 41.1 (38.7, 43.5) 6.2 3.5 8.9
    19-29 11.6 (9.4, 13.9) 13.2 (9.6, 16.7) 1.5 -2.6 5.7
    30-39 26.2 (23.5, 28.8) 28.5 (23.0, 34.1) 2.4 -3.8 8.5
    40-49 37.9 (35.1, 40.7) 47.5 (42.4, 52.6) 9.6 3.8 15.4
    50-59 44.8 (42.1, 47.5) 55.4 (50.6, 60.1) 10.6 5.1 16.1
    60-69 50.3 (47.5, 53.0) 52.7 (46.7, 58.7) 2.5 -4.2 9.1
    ≥70 49.4 (46.5, 52.4) 55.5 (50.8, 60.2) 6.1 0.6 11.6
    Female, age ≥19 (yr) 28.0 (26.8, 29.2) 29.5 (27.2, 31.7) 1.5 -1.2 4.1
    19-29 4.8 (3.3, 6.2) 6.9 (4.2, 9.5) 2.1 -1.0 5.1
    30-39 8.8 (7.0, 10.5) 11.5 (7.7, 15.3) 2.7 -1.5 7.0
    40-49 15.5 (13.6, 17.4) 14.8 (11.3, 18.4) -0.7 -4.7 3.3
    50-59 30.4 (28.1, 32.7) 31.3 (27.0, 35.7) 0.9 -4.1 5.9
    60-69 52.7 (50.0, 55.4) 52.0 (47.3, 56.7) -0.7 -6.2 4.8
    ≥70 66.6 (64.2, 68.9) 66.0 (61.8, 70.3) -0.5 -5.4 4.3
    Marital status
    Single 13.7 (12.2, 15.2) 17.9 (15.3, 20.6) 4.2 1.2 7.3
    Married (cohabitation) 34.7 (33.5, 35.8) 38.9 (36.6, 41.2) 4.2 1.6 6.9
    Divorced/Widowed/Separated 50.3 (48.0, 52.5) 53.5 (49.6, 57.5) 3.3 -1.3 7.8
    Education
    ≤Middle school 55.0 (53.4, 56.7) 57.6 (53.7, 61.4) 2.5 -1.7 6.8
    High school 34.3 (32.7, 35.9) 36.7 (33.4, 39.9) 2.3 -1.3 5.9
    ≥College 20.6 (19.6, 21.6) 25.7 (23.9, 27.5) 5.1 3.1 7.2
    Household income
    Low 33.6 (31.9, 35.3) 38.2 (34.8, 41.5) 4.6 0.8 8.4
    Low-middle 32.3 (30.6, 34.0) 33.2 (30.2, 36.2) 0.9 -2.6 4.4
    Middle-high 31.2 (29.6, 32.8) 35.8 (32.8, 38.9) 4.6 1.2 8.1
    High 28.7 (27.0, 30.3) 34.0 (30.9, 37.0) 5.3 1.8 8.8
    Occupation
    Administrators and specialists 22.9 (21.2, 24.7) 26.8 (23.7, 29.9) 3.9 0.3 7.5
    Office worker 24.3 (22.0, 26.6) 29.3 (24.6, 33.9) 5.0 -0.3 10.2
    Service workers and marketers 28.8 (26.7, 31.0) 33.6 (29.3, 38.0) 4.8 0.0 9.7
    Agriculture, forestry, and fishery 51.5 (46.6, 56.5) 47.7 (34.7, 60.7) -3.8 -17.8 10.1
    Engineers, technicians, and assemblers 34.9 (32.3, 37.5) 40.5 (35.6, 45.3) 5.6 0.1 11.1
    Manual laborers 38.3 (35.4, 41.3) 39.3 (34.3, 44.3) 1.0 -4.9 6.9
    Homemakers and students 34.7 (33.2, 36.3) 35.9 (33.3, 38.5) 1.2 -2.0 4.3
    Table 1. General characteristics of the KNHANES participants from 2017 to 2020

    Values are presented as number (weighted %) or mean±standard error.

    KNEANES, Korea National Health and Nutritional Examination Survey; DM, diabetes mellitus; HBP, high blood pressure; BP, blood pressure, BMI, body mass index; LDL, low-density lipoprotein; HDL, high-density lipoprotein.

    Table 2. Changes in the prevalence of metabolic syndrome in 2020 compared to 3 years before the COVID-19 pandemic

    Values are presented as weighted % (95% CI).

    COVID-19, coronavirus disease 2019; CI, confidence interval; %p, percentage points; LL, lower limit; UL, upper limit.

    Table 1.

    Table 2.

    Epidemiol Health : Epidemiology and Health
    © Korean Society of Epidemiology.
    TOP